Tetsuya Mitsudomi
@t_mitsudomiProfessor, Thoracic Surgery, Kindai University, Osaka, Japan, Interested in Translational research of lung cancer. Play the cello a little bit.
Similar User
@fred_hirsch
@DrRoyHerbstYale
@oncoOuLungCA
@HosseinBorghaei
@RamalingamMD
@MLJohnsonMD2
@JTOonline
@geoff_oxnard
@EGFRResisters
@JSabari
@dplanchard
@CoreyLangerMD
@drgandara
@bensolomon1
@LealTiciana
このパワポのスライドにつける付箋の作り方良いね。 可愛い感じの付箋で見栄え良いよ。 prezen-square.jp/posts/100views…
ecDNA fuels cancer progression: large, mobile circles of DNA in tumors drive high oncogene copies & rapid genetic changes. Their random spread during cell division increases treatment resistance & tumor evolution. Determining therapeutic vulnerabilities & identifying target…
ecDNA are rogue genetic material that amplify genes, contribute to treatment resistance and drive genomic heterogeneity. We report on the Origins and impact of extrachromosomal DNA today in @Nature nature.com/articles/s4158…
🔥#ESMO24 Proffered Paper: NSCLC metastatic ✅Chairs: @BenjaminBesseMD @GarassinoMarina 🎙️@DrSanjayPopat 🎯MARIPOSA-2: Ami + chemo vs chemo in EGFR-m NSCLC after progression on osimertinib #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Proffered Paper: NSCLC metastatic ✅Chairs: @BenjaminBesseMD @GarassinoMarina 🎙️@BenjaminBesseMD 🎯MARIPOSA: Mechanisms of acquired resistance to 1st-L ami + laz versus osi in pts with EGFR-m NSCLC #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Proffered Paper: NSCLC metastatic ✅Chairs: @BenjaminBesseMD @GarassinoMarina 🎙️@alexdrilon 🎯Phase I/II ALKOVE-1 study of NVL-655 in ALK-positive solid tumours #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️@BenjaminBesseMD 🎯Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1+ solid tumours #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️@APassaroMD 🎯Zipalertinib in pts with EGFR exon 20 insertion mutations after prior ami #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️@barlesi 🎯KRYSTAL-12: Adagrasib vs doc in KRASG12C-m NSCLC with baseline brain mets #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️Dr. María De Miguel 🎯ABBV-400 (c-Met ADC) in pts with advanced EGFR WT non-sq NSCLC #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️Dr. Gregory Riely 🎯PHAROS: Encorafenib plus binimetinib in pts with BRAF V600E-m NSCLC #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️Dr. Michel van den Heuvel 🎯NVALT-30: Low dose versus standard dose pembrolizumab #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️@dplanchard 🎯IFCT-1904 ENCO-BRAF: Encorafenib + binimetinib in untreated BRAF V600E-m NSCLC #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: NSCLC metastatic 📷✅Chairs: Dr. Adrianus Johannes De Langen @MarianaBrandao0 @oncoOuLungCA 🎙️@ThomasW35874311 🎯PM8002/BNT327 + chemo in pts with EGFR-m NSCLC #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: Non-metastatic NSCLC ✅Chairs: @CelineMascaux Drs. Antonio Calles Blanco, Jia Wu 🎙️@DoctorJSpicer 🎯CheckMate 77T: Periope NIVO vs PBO in pts with resectable NSCLC #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: Non-metastatic NSCLC ✅Chairs: @CelineMascaux Drs. Antonio Calles Blanco, Jia Wu 🎙️@Joshua_Reuss 🎯NEOSTAR and CA209-159: Combined analysis of 5-year outcomes #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: Non-metastatic NSCLC ✅Chairs: @CelineMascaux Drs. Antonio Calles Blanco, Jia Wu 🎙️@MartinReck2 🎯AEGEAN: Associations of ctDNA clearance during neoadjuvant Tx with pathological response and EFS #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
🔥#ESMO24 Mini oral session: Non-metastatic NSCLC ✅Chairs: @CelineMascaux Drs. Antonio Calles Blanco, Jia Wu 🎙️@AndrearicFili 🎯DUART: ctDNA dynamics and Tx responses in chemo-ineligible pts with unresectable stage III NSCLC #LCSM @myESMO @OncoAlert cslide.ctimeetingtech.com/esmo2024/atten…
✴️#ESMO24 🔝 Abstracts #LCSM 💯Best coverage by @OncoAlert
Dear Colleagues, The @OncoAlert 🚨Network Presents OUR Picks of TOP 🔟 #LungCancer 🫁Abstracts to be Presented at #ESMO24 This List Curated by: #OncoAlertAF Leads @HHorinouchi 🇯🇵 @BiagioRicciutMD 🇺🇸 @lungoncdoc 🇺🇸 @weoncologists 🇺🇸 With our Distinguished @OncoAlert 🚨Faculty…
United States Trends
- 1. Mike 1,7 Mn posts
- 2. Serrano 227 B posts
- 3. #NetflixFight 66,4 B posts
- 4. Canelo 14 B posts
- 5. #netflixcrash 14,6 B posts
- 6. Father Time 10,3 B posts
- 7. Rosie Perez 13,3 B posts
- 8. Logan 71,6 B posts
- 9. #buffering 10,4 B posts
- 10. Shaq 14,3 B posts
- 11. #boxing 41,6 B posts
- 12. ROBBED 96,2 B posts
- 13. My Netflix 77,5 B posts
- 14. He's 58 18,2 B posts
- 15. Tori Kelly 4.762 posts
- 16. Ramos 69,2 B posts
- 17. Roy Jones 6.631 posts
- 18. Cedric 20,2 B posts
- 19. Gronk 6.269 posts
- 20. Barrios 49,9 B posts
Who to follow
-
Fred R. Hirsch
@fred_hirsch -
Roy Herbst
@DrRoyHerbstYale -
Sai-Hong Ignatius Ou
@oncoOuLungCA -
Hossein Borghaei, DO
@HosseinBorghaei -
Suresh S. Ramalingam, MD, FASCO
@RamalingamMD -
Melissa L. Johnson
@MLJohnsonMD2 -
JTO & JTO CRR
@JTOonline -
Geoff Oxnard MD
@geoff_oxnard -
EGFR Resisters
@EGFRResisters -
Joshua Sabari, MD
@JSabari -
d.planchard
@dplanchard -
Corey Langer
@CoreyLangerMD -
David Gandara
@drgandara -
Ben Solomon
@bensolomon1 -
Ticiana Batista (Leal)
@LealTiciana
Something went wrong.
Something went wrong.